• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲磺酸伊马替尼成功治疗乳腺隆突性皮肤纤维肉瘤肺转移:1例报告

Successful treatment of metastatic dermatofibrosarcoma protuberans of the breast to the lungs with imatinib mesylate: a case report.

作者信息

Kpatsi Stephen, Daniels Joseph, Kyei Kofi Adesi, Vanderpuye Verna

机构信息

National Radiotherapy, Oncology and Nuclear Medicine Centre, Korle Bu Teaching Hospital, Accra, Ghana.

https://orcid.org/0009-0005-8954-0509.

出版信息

Ecancermedicalscience. 2025 May 27;19:1912. doi: 10.3332/ecancer.2025.1912. eCollection 2025.

DOI:10.3332/ecancer.2025.1912
PMID:40556795
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12185871/
Abstract

Dermatofibrosarcoma protuberans (DFSPs) is a low-grade mesenchymal tumour of dermal origin. Although lung metastasis is common, primary breast involvement is a very rare occurrence. The head and neck region, trunk and extremities are the common primary sites even though any site of the body may be potentially involved. Complete surgical resection with negative margins is the standard of care for nonmetastatic cases of DFSP. To the best of our knowledge, there have been no previous reports of metastatic DFSP of the breast to the lungs among male patients in sub-Saharan Africa. This case report presents data on a 32-year-old male with metastatic DFSP of the left breast to the lungs who was successfully treated with 800 mg daily imatinib mesylate therapy and achieved a complete radiological and clinical response after 1 year of palliative therapy.

摘要

隆突性皮肤纤维肉瘤(DFSPs)是一种起源于真皮的低度间叶性肿瘤。虽然肺转移很常见,但原发性乳腺受累极为罕见。头颈部、躯干和四肢是常见的原发部位,尽管身体的任何部位都有可能受累。对于非转移性DFSP病例,切缘阴性的完整手术切除是标准治疗方法。据我们所知,撒哈拉以南非洲地区此前尚无男性患者乳腺DFSP转移至肺部的报道。本病例报告介绍了一名32岁男性患者的数据,该患者左乳DFSP转移至肺部,接受每日800毫克甲磺酸伊马替尼治疗后成功治愈,姑息治疗1年后实现了影像学和临床完全缓解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2497/12185871/3a7c0762f8f1/can-19-1912fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2497/12185871/cf8a9ccebf31/can-19-1912fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2497/12185871/996a98f95810/can-19-1912fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2497/12185871/929a385c045e/can-19-1912fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2497/12185871/3a7c0762f8f1/can-19-1912fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2497/12185871/cf8a9ccebf31/can-19-1912fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2497/12185871/996a98f95810/can-19-1912fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2497/12185871/929a385c045e/can-19-1912fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2497/12185871/3a7c0762f8f1/can-19-1912fig4.jpg

相似文献

1
Successful treatment of metastatic dermatofibrosarcoma protuberans of the breast to the lungs with imatinib mesylate: a case report.甲磺酸伊马替尼成功治疗乳腺隆突性皮肤纤维肉瘤肺转移:1例报告
Ecancermedicalscience. 2025 May 27;19:1912. doi: 10.3332/ecancer.2025.1912. eCollection 2025.
2
Imatinib for the treatment of patients with unresectable and/or metastatic gastrointestinal stromal tumours: systematic review and economic evaluation.伊马替尼治疗不可切除和/或转移性胃肠道间质瘤患者:系统评价与经济学评估
Health Technol Assess. 2005 Jul;9(25):1-142. doi: 10.3310/hta9250.
3
Taxane monotherapy regimens for the treatment of recurrent epithelial ovarian cancer.紫杉烷类单药治疗方案用于复发性上皮性卵巢癌。
Cochrane Database Syst Rev. 2022 Jul 12;7(7):CD008766. doi: 10.1002/14651858.CD008766.pub3.
4
Negative pressure wound therapy for surgical wounds healing by primary closure.负压伤口疗法在一期缝合手术伤口愈合中的应用。
Cochrane Database Syst Rev. 2022 Apr 26;4(4):CD009261. doi: 10.1002/14651858.CD009261.pub7.
5
Systemic interventions for treatment of Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS/TEN overlap syndrome.全身性治疗史蒂文斯-约翰逊综合征(SJS)、中毒性表皮坏死松解症(TEN)和 SJS/TEN 重叠综合征。
Cochrane Database Syst Rev. 2022 Mar 11;3(3):CD013130. doi: 10.1002/14651858.CD013130.pub2.
6
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.成人全身麻醉后预防术后恶心呕吐的药物:网状Meta分析
Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2.
7
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
8
Antioxidants for female subfertility.用于女性生育力低下的抗氧化剂。
Cochrane Database Syst Rev. 2017 Jul 28;7(7):CD007807. doi: 10.1002/14651858.CD007807.pub3.
9
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
10
Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature.吸入装置在哮喘和慢性阻塞性气道疾病中的有效性比较:文献系统评价
Health Technol Assess. 2001;5(26):1-149. doi: 10.3310/hta5260.

本文引用的文献

1
Survival Outcomes and Prognostic Factors of Dermatofibrosarcoma Protuberans: A Population-Based Retrospective Cohort Analysis.隆突性皮肤纤维肉瘤的生存结局和预后因素:基于人群的回顾性队列分析。
Dermatol Surg. 2023 Sep 1;49(9):825-831. doi: 10.1097/DSS.0000000000003853. Epub 2023 Jun 22.
2
Advanced dermatofibrosarcoma protuberans: an updated analysis of cases from an Indian sarcoma clinic.隆突性皮肤纤维肉瘤:来自一家印度肉瘤诊所病例的最新分析
Future Sci OA. 2021 Jun 30;7(9):FSO743. doi: 10.2144/fsoa-2020-0198. eCollection 2021 Oct.
3
A Rare Malignant Disease, Dermatofibrosarcoma Protuberans of the Breast: A Retrospective Analysis and Review of Literature.
罕见恶性疾病,乳腺隆突性皮肤纤维肉瘤:回顾性分析及文献复习。
Biomed Res Int. 2020 Nov 9;2020:8852182. doi: 10.1155/2020/8852182. eCollection 2020.
4
Role of postoperative radiotherapy in dermatofibrosarcoma protuberans: a propensity score-matched analysis.术后放疗在隆突性皮肤纤维肉瘤中的作用:倾向评分匹配分析。
Radiat Oncol. 2019 Jan 29;14(1):20. doi: 10.1186/s13014-019-1226-z.
5
Dermatofibrosarcoma Protuberans of Distal Extremities and Acral Sites: A Clinicopathologic Analysis of 27 Cases.远端肢体和肢端部位隆突性皮肤纤维肉瘤:27 例临床病理分析。
Am J Surg Pathol. 2018 Mar;42(3):413-419. doi: 10.1097/PAS.0000000000000998.
6
Clinical Features, Pathological Findings and Treatment of Recurrent Dermatofibrosarcoma Protuberans.复发性隆突性皮肤纤维肉瘤的临床特征、病理表现及治疗
J Cancer. 2017 May 12;8(7):1319-1323. doi: 10.7150/jca.17988. eCollection 2017.
7
Risk factors for distant metastasis of dermatofibrosarcoma protuberans.隆突性皮肤纤维肉瘤远处转移的危险因素。
J Orthop Traumatol. 2016 Sep;17(3):261-6. doi: 10.1007/s10195-016-0415-x. Epub 2016 Jun 11.
8
Imatinib mesylate in advanced dermatofibrosarcoma protuberans: pooled analysis of two phase II clinical trials.甲磺酸伊马替尼治疗晚期隆突性皮肤纤维肉瘤:两项 II 期临床试验的汇总分析。
J Clin Oncol. 2010 Apr 1;28(10):1772-9. doi: 10.1200/JCO.2009.25.7899. Epub 2010 Mar 1.
9
Cutaneous soft tissue sarcoma incidence patterns in the U.S. : an analysis of 12,114 cases.美国皮肤软组织肉瘤的发病模式:对12114例病例的分析。
Cancer. 2008 Aug 1;113(3):616-27. doi: 10.1002/cncr.23571.
10
Dermatofibrosarcoma protuberans: A clinicopathologic analysis of patients treated and followed at a single institution.隆突性皮肤纤维肉瘤:对在单一机构接受治疗及随访的患者的临床病理分析
Cancer. 2000 Jun 15;88(12):2711-20.